Buscar
01/06/2022
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience
Salvatori, R, Maffei, P, Webb, SM, Brue, T, Loftus, J, Valluri, SR, Gomez, R, Wajnrajch, MP, Fleseriu, M. Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience. Pituitary. 2022; 25(3)DOI:10.1007/s11102-022-01206-2. PMID:35022929. IF:3.800(Q2/5D).
28/05/2022
Data mining analyses for precision medicine in acromegaly: a proof of concept
Gil, J, Marques-Pamies, M, Sampedro, M, Webb, SM, Serra, G, Salinas, I, Blanco, A, Valassi, E, Carrato, C, Pico, A, Garcia-Martinez, A, Martel-Duguech, L, Sardon, T, Simo-Servat, A, Biagetti, B, Villabona, C, Camara, R, Fajardo-Montanana, C, Alvarez-Escola, C, Lamas, C, Alvarez, CV, Bernabeu, I, Marazuela, M, Jorda, M, Puig-Domingo, M. Data mining analyses for precision medicine in acromegaly: a proof of concept. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-12955-2. PMID:35643771. IF:4.600(Q2/4D).
01/02/2022
Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
Pardo, JC, de Porras, VR, Gil, J, Font, A, Puig-Domingo, M, Jorda, M. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer. Nutrients. 2022; 14(4)DOI:10.3390/nu14040851. PMID:35215499. IF:5.900(Q1/2D).
01/01/2022
Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)
van Haalen F.M., Kaya M., Pelsma I.C.M., Cannegieter S.C., Huisman M.V., van Vlijmen B.J.M., Feelders R.A., Stochholm K., Fliers E., Castinetti F., Brue T., Bertherat J., Scaroni C., Colao A., Giordano R., Druce M.R., Beckers A., Spranger J., Driessens N., Maiter D., Feldt-Rasmussen U., Feelders R., Webb S.M., Dattani M., Husebye E., Zilaitiene B., Gaztambide S., Gatto F., Ferone D., Persani L., Chiodini I., Höybye C., Pereira A.M., Biermasz N.R., Klok F.A., Dekkers O.M., Meijer O.C., Reincke M., Vila G., Perry C., Heck A., Stancampiano M.R., van de Ven A., Johannsson G., Ragnarsson O., Tóth M., Volke V., Toumba M., Canu L., Vojtková J., Al-Mrayat M., Fassnacht M., Detomas M., Karavitaki N., van der Klauw M.M., Groselj U., Elenkova A., Unuane D.. Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02320-x. PMID:35505430. IF:3.700(Q2/4D).
01/12/2025
Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors
Araujo-Castro, M, Torre, EM, Lozano-Aida, C, Garcia-Centeno, R, Fernandez, LG, Idrobo, C, Achote-Rea, E, Echarri, AI, Rodriguez-Argullo, MDM, Paja, M, Guerrero-Perez, F, Castano, JP, Garcia, MDO, Novo-Rodriguez, C, Tenorio-Jimenez, C, Villar-Taibo, R, Bernabeu, I, Diaz-Lopez, E, Calatayud, M, Alvarez-Escola, C, Rojas-Marcos, PM, Recio-Cordova, JM, Aulinas, A, Roca, QA, Aviles, MD, Mezquita, EL, Fernandez-Argueeso, M, Molero, IG, Ruz-Caracuel, I, Aldecoa, I, Garcia, J, Martinez-Saez, E, Hanzu, F, Marazuela, M, Puig-Domingo, M, Biagetti, B. Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(12)DOI:10.1210/clinem/dgaf252. PMID:40277238. IF:5.100(Q1/2D).
01/12/2025
Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With Obesity
Aulinas, A, Galbiati, F, Wronski, ML, Carter, CS, Nazarloo, S, Holman, K, Golden, ER, Muhammed, M, Hadaway, N, Asanza, E, Smith, SE, Plessow, F, Lawson, EA. Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With Obesity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(12)DOI:10.1210/clinem/dgaf237. PMID:40314146. IF:5.100(Q1/2D).
01/12/2025
Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study
Biagetti, B, Cardona-Arias, A, Torre, EM, Aulinas, A, Ruz-Caracuel, I, Centeno, RG, Gonzalez, L, Echarri, AI, Rodriguez, MDM, Paja, M, Guerrero-Perez, F, Castano, JP, Garcia, MDO, Novo-Rodriguez, C, Tenorio-Jimenez, C, Villar-Taibo, R, Bernabeu, I, Diaz-Lopez, E, Calatayud, M, Alvarez-Escola, C, Rojas-Marcos, PM, Recio-Cordova, JM, Lozano-Aida, C, Roca, QA, Aviles, MD, Mezquita, EL, Argueso, MF, Molero, IG, Alberoa, I, Idrobo, C, Achote, E, Martinez-Saez, E, Marazuela, M, Puig-Domingo, M, Hanzu, F, Araujo-Castro, M. Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2025; 48(12)DOI:10.1007/s40618-025-02674-6. PMID:40779234. IF:3.500(Q2/4D).
01/11/2025
Oxytocin in hypopituitarism: What do we know?
Aulinas, A, Lawson, EA. Oxytocin in hypopituitarism: What do we know?. Endocrinologia Diabetes y Nutricion. 2025; 72(9)DOI:. PMID:41173566. IF:1.800(Q3/8D).